- Home
- CTOS vs ANIP Comparison
CTOS vs ANIP Comparison
Compare CTOS & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTOS
- ANIP
- Stock Information
- Founded
- CTOS 1988
- ANIP 2001
- Country
- CTOS United States
- ANIP United States
- Employees
- CTOS N/A
- ANIP N/A
- Industry
- CTOS Diversified Commercial Services
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- CTOS Consumer Discretionary
- ANIP Health Care
- Exchange
- CTOS Nasdaq
- ANIP Nasdaq
- Market Cap
- CTOS 1.1B
- ANIP 1.3B
- IPO Year
- CTOS N/A
- ANIP N/A
- Fundamental
- Price
- CTOS $4.76
- ANIP $65.56
- Analyst Decision
- CTOS Hold
- ANIP Strong Buy
- Analyst Count
- CTOS 3
- ANIP 8
- Target Price
- CTOS $5.33
- ANIP $80.13
- AVG Volume (30 Days)
- CTOS 359.5K
- ANIP 296.7K
- Earning Date
- CTOS 07-31-2025
- ANIP 08-05-2025
- Dividend Yield
- CTOS N/A
- ANIP N/A
- EPS Growth
- CTOS N/A
- ANIP N/A
- EPS
- CTOS N/A
- ANIP N/A
- Revenue
- CTOS $1,813,205,000.00
- ANIP $674,068,000.00
- Revenue This Year
- CTOS $11.08
- ANIP $30.52
- Revenue Next Year
- CTOS $5.69
- ANIP $7.40
- P/E Ratio
- CTOS N/A
- ANIP N/A
- Revenue Growth
- CTOS N/A
- ANIP 30.27
- 52 Week Low
- CTOS $3.03
- ANIP $52.50
- 52 Week High
- CTOS $6.11
- ANIP $77.00
- Technical
- Relative Strength Index (RSI)
- CTOS 60.17
- ANIP 60.18
- Support Level
- CTOS $4.65
- ANIP $62.81
- Resistance Level
- CTOS $4.86
- ANIP $64.45
- Average True Range (ATR)
- CTOS 0.15
- ANIP 1.88
- MACD
- CTOS 0.01
- ANIP 0.71
- Stochastic Oscillator
- CTOS 84.96
- ANIP 97.37
About CTOS Custom Truck One Source Inc.
Custom Truck One Source Inc is a one-stop-shop provider of specialty equipment in the electric utility transmission and distribution, forestry, telecom, waste management, rail, and infrastructure end-markets in North America. The company's segment includes Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS). It generates maximum revenue from the TES segment. Geographically, it derives a majority revenue from the United States.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.